Concepedia

S. A. Roumiantsev

SA

33

Publications

2K

Citations

23

H-Index

2001

Active since

Affiliations

Institute of Bioorganic Chemistry(Current)

Pirogov Russian National Research Medical University

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology

Moscow Institute of Physics and Technology

Harvard University

S. A. Roumiantsev is an author at Institute of Bioorganic Chemistry specializing in medicine, systems biology, and tumor biology.

ORCID

Top concepts

Publications per year

2001–2022

33

Publications

33

Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project

Ozge Ceyhan‐Birsoy, Jaclyn B. Murry, Kalotina Machini et al. · The American Journal of Human Genetics · 2019 · 295 citations · Full text

, , +11

Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop

S. A. Roumiantsev, Neil P. Shah, M. Gorre et al. · Proceedings of the National Academy of Sciences · 2002 · 257 citations · Full text

, , +17

Differential Roles of Sall4 Isoforms in Embryonic Stem Cell Pluripotency

Sridhar Rao, Zhen Shao, S. A. Roumiantsev et al. · Molecular and Cellular Biology · 2010 · 180 citations · Full text

Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield

Cynthia S. Gubbels, Grace E. VanNoy, Jill A. Madden et al. · Genetics in Medicine · 2019 · 118 citations · Full text

, , +13

The Src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase

S. A. Roumiantsev · Blood · 2001 · 95 citations · Full text

Rows per page

1–5 of 33